Pulse ·

One in three GP practices offers medical abortion. Location decides the rest.

By Dr HB Lo, FACRRM 4 min read
Verdict Yes — worth knowing about

Only one in three Australian general practices provided early medication abortion between 2014 and 2021, and more than half of women seeking the service had to attend a practice they had never visited before. Despite a twentyfold rise in GP provision since 2014, Australia's rate lags well behind comparable countries — medication abortion accounts for around half of all Australian abortions, versus more than 90% in countries like Sweden and Finland. Geography remains the most significant barrier, with regional areas recording higher provision rates largely because surgical alternatives are unavailable locally, not because access is better.

What just happened

A major study published in BMJ Sexual & Reproductive Health has drawn a clear line between postcode and access to medical abortion in Australia — and the line falls in ways that should prompt reflection about what reproductive healthcare actually means in general practice.

Researchers from Flinders University analysed data from more than one million women across 400 general practices in six states and territories between 2014 and 2021. The headline finding: medication abortion through GPs rose twentyfold over the study period. The finding underneath it: only about one in three practices offered the service at all, and more than half of women receiving medication abortion had to see a GP they had never consulted before.

For a service with a nine-week time limit, attending an unfamiliar provider under time pressure is not a minor inconvenience. It represents a structural gap between the legal availability of a service and its practical accessibility.

The both-and

What has genuinely changed

The scale of growth is real. In 2014, medication abortion was provided to roughly one in 10,000 women through general practice. By 2021, that figure had grown to about one in 500. The proportion of practices offering the service rose from around one in 25 to about one in five. Medication abortion is now legally deregulated, increasingly covered by Medicare, and accessible by telehealth in ways that simply were not possible a decade ago.

The 2023 TGA changes — removing restrictions on mifepristone and misoprostol and allowing pharmacies to dispense without specialist oversight — and the introduction of MBS telehealth item numbers have genuinely lowered structural barriers. These are material wins.

And yet. Australia’s medication abortion rate sits at around half of all abortions, compared to more than 90 percent in Finland, Sweden, and India — countries where medication abortion is the default, not an add-on. The gap between policy progress and real-world access is not closing as fast as the legal landscape suggests it should.

What hasn’t changed — and why

The study’s regional finding is striking: provision rates were twice as high in regional practices as in major cities. On the surface, that looks like rural success. The researchers and clinicians interviewed read it differently.

Regional areas record higher provision rates in part because they have no surgical alternative. Professor Kirsten Black, a sexual and reproductive health academic at the University of Sydney, is cited in The Medical Republic’s coverage noting that only three hospitals in New South Wales provide surgical abortion across the entire state. When medication abortion is the only accessible option, higher provision rates don’t signal a more progressive clinical culture — they signal necessity.

Other barriers identified in the research include ongoing stigma (some GPs in rural areas were reluctant to be known as the “abortion doctor”), religious and moral objections without a corresponding mandatory refer-on obligation, limited hospital backup for the approximately 5 percent of cases where medication abortion does not succeed, and insufficient remuneration for the consultation time required. The mandatory refer-on obligation for GPs with conscientious objections was stripped from the NSW Greens bill before it passed in the upper house last year.

The 56.9% of women who attended a new practice is the figure to sit with. Professor Danielle Mazza from Monash University described this as “quite concerning,” particularly given the time-sensitive nature of the service. Women without an existing relationship with a provider who offers medication abortion must establish one — often quickly and often under stress.

The shifting patient landscape

Professor Mazza raised a structural observation that extends beyond abortion specifically: as contraception and UTI treatment increasingly move into pharmacies, the GP relationship through which reproductive health conversations historically happened naturally is less likely to exist. For services that carry any degree of social complexity, the absence of an established GP relationship is not a neutral starting point.

The RACGP’s AusCAPPS Network exists specifically to support GPs and registrars who want training, peer support, and referral networks for providing medical abortion. Awareness of this resource — among both clinicians and patients — remains lower than the need warrants.

My two cents

The nine-week limit doesn’t tolerate discovery delays. A woman who realises she is pregnant at six weeks has roughly three weeks to navigate a system where the majority of practices don’t offer the service she needs, find a provider willing to see a new patient, book and attend that appointment, and access the medication. That window is not comfortable under any circumstances, and it narrows further for women in regional areas, women without transport, women with caring responsibilities, or women experiencing housing instability.

The practical implication for GPs who don’t provide medication abortion is simple: knowing which nearby practice does — and being able to say so directly in the consultation — is itself a clinical service. It removes one of the obstacles the data identifies: a woman having to navigate the system alone, under time pressure, without knowing where to go.

For GPs and registrars considering whether to add medication abortion to their scope, the RACGP’s Check program module on medical abortion and the AusCAPPS Network are the entry points. The policy architecture has largely been built. The gap now is training uptake, stigma reduction, and a referral infrastructure fast enough to work when it matters.

Verdict: yes — worth knowing about.

Sources cited

  1. Location a key barrier to medical abortion: Study. RACGP NewsGP, 21 July 2026. https://www1.racgp.org.au/newsgp/professional/location-a-key-barrier-to-medical-abortion-study
  2. GP abortion care still falling short. The Medical Republic, 21 July 2026. https://www.medicalrepublic.com.au/gp-abortion-care-still-falling-short/127480
  3. AusCAPPS Network. https://www.auscapps.org.au

Frequently asked questions

  • How do I find a GP who provides medication abortion?

    The AusCAPPS Network connects patients with GPs trained in abortion provision. Family Planning clinics in each state are another access point. Because more than half of Australian women currently have to see a new GP for this service, knowing where to go before you need the service is practical — the nine-week time limit on medication abortion leaves little room for discovery under pressure.

  • Is medication abortion available via telehealth?

    Since mid-2023, dedicated MBS telehealth item numbers allow GPs to provide medication abortion without requiring an in-person visit, provided the pregnancy is under nine weeks and clinical criteria are met. The TGA's deregulation of mifepristone and misoprostol (MS-2 Step) simplified pharmacy dispensing. Access still depends on whether a GP is trained and willing to provide the service — which is why finding a provider in advance, rather than under time pressure, matters.